{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:05:18Z","timestamp":1779869118579,"version":"3.53.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020258","name":"Department of Molecular Medicine, University of Pavia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020258","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19-AI171954"],"award-info":[{"award-number":["U19-AI171954"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.slasd.2025.100262","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T06:40:37Z","timestamp":1754980837000},"page":"100262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle"],"prefix":"10.1016","volume":"35","author":[{"given":"Emery","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2799-9611","authenticated-orcid":false,"given":"Justin","family":"Shumate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Otsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7734-0105","authenticated-orcid":false,"given":"Louis","family":"Scampavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0683-8886","authenticated-orcid":false,"given":"Thomas D.","family":"Bannister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9080-4226","authenticated-orcid":false,"given":"Timothy P.","family":"Spicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.slasd.2025.100262_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077602","article-title":"Cost of the COVID-19 pandemic versus the cost-effectiveness of mitigation strategies in EU\/UK\/OECD: a systematic review","volume":"13","author":"Vardavas","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.slasd.2025.100262_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1288686","article-title":"Structural understanding of SARS-CoV-2 virus entry to host cells","volume":"10","author":"Le","year":"2023","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.slasd.2025.100262_bib0003","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.slasd.2025.100262_bib0004","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors","volume":"363","author":"Liu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.slasd.2025.100262_bib0005","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1080\/22221751.2022.2095308","article-title":"An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry","volume":"11","author":"Lin","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.slasd.2025.100262_bib0006","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/2472555218820809","article-title":"The scripps molecular screening center and translational research institute","volume":"24","author":"Baillargeon","year":"2019","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0007","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/s41392-021-00712-2","article-title":"Structural and functional basis for pan-CoV fusion inhibitors against SARS-CoV-2 and its variants with preclinical evaluation","volume":"6","author":"Xia","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.slasd.2025.100262_bib0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.slasd.2025.100262_bib0009","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01650-22","article-title":"Cytoplasmic tail truncation stabilizes S1-S2 association and enhances S protein incorporation into SARS-CoV-2 pseudovirions","volume":"97","author":"Zhang","year":"2023","journal-title":"J Virol"},{"key":"10.1016\/j.slasd.2025.100262_bib0010","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.slasd.2021.10.012","article-title":"Identification of potent small molecule inhibitors of SARS-CoV-2 entry","volume":"27","author":"Mediouni","year":"2022","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100178","article-title":"Simultaneous screening for selective SARS-CoV-2, Lassa, and Machupo virus entry inhibitors","volume":"29","author":"Otsuka","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100180","article-title":"High throughput screening for SARS-CoV-2 helicase inhibitors","volume":"29","author":"Otsuka","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100181","article-title":"SARS-CoV-2 M(pro) inhibitor identification using a cellular gain-of-signal assay for high-throughput screening","volume":"29","author":"Delgado","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.slasd.2024.100164","article-title":"A high-throughput cell-based screening method for Zika virus protease inhibitor discovery","volume":"29","author":"Anindita","year":"2024","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.slasd.2025.100262_bib0016","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100262_bib0017","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1021\/ja0170302","article-title":"A combinatorial scaffold approach toward kinase-directed heterocycle libraries","volume":"124","author":"Ding","year":"2002","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.slasd.2025.100262_bib0018","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","article-title":"The growing impact of click chemistry on drug discovery","volume":"8","author":"Kolb","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.slasd.2025.100262_bib0019","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.1021\/jm901241e","article-title":"Escape from flatland: increasing saturation as an approach to improving clinical success","volume":"52","author":"Lovering","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.slasd.2025.100262_bib0020","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S1359-6446(03)02831-9","article-title":"A 'rule of three' for fragment-based lead discovery?","volume":"8","author":"Congreve","year":"2003","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.slasd.2025.100262_bib0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.slasd.2025.100262_bib0022","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.slasd.2022.03.002","article-title":"Lead identification using 3D models of pancreatic cancer","volume":"27","author":"Fernandez-Vega","year":"2022","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0023","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.slasd.2023.01.001","article-title":"High throughput screening for drugs that inhibit 3C-like protease in SARS-CoV-2","volume":"28","author":"Smith","year":"2023","journal-title":"SLAS Discov"},{"key":"10.1016\/j.slasd.2025.100262_bib0024","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s42770-022-00743-z","article-title":"Spike protein of SARS-CoV-2 variants: a brief review and practical implications","volume":"53","author":"Candido","year":"2022","journal-title":"Braz J Microbiol"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2472555225000553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:32:28Z","timestamp":1779867148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2472555225000553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":24,"alternative-id":["S2472555225000553"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100262","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High throughput screening for SARS-CoV-2 inhibitors targeting 5 helix bundle","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100262"}}